Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Malignant Melanoma

  Free Subscription


22.06.2020

2 Ann Surg Oncol
1 Br J Dermatol
1 Cancer Res
1 J Invest Dermatol
2 Lancet
2 Lancet Oncol
1 Ophthalmology
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg Oncol

  1. HAYWOOD S, Garioch J, Ramaiya A, Moncrieff M, et al
    Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy.
    Ann Surg Oncol. 2020 Jun 15. pii: 10.1245/s10434-020-08713.
    PubMed         Abstract available

  2. MORRISON S, Han D
    ASO Author Reflections: Sentinel Lymph Node Biopsy is Prognostic in the Thickest Melanoma Cases and Should be Performed for Thick Melanomas.
    Ann Surg Oncol. 2020 Jun 12. pii: 10.1245/s10434-020-08725.
    PubMed        


    Br J Dermatol

  3. HOLLESTEIN LM, Nijsten T
    Survival is excellent for most patients with thin melanoma, but patients may die from thin melanoma.
    Br J Dermatol. 2020 Jun 15. doi: 10.1111/bjd.19208.
    PubMed        


    Cancer Res

  4. SACHDEVA R, Wu M, Smiljanic S, Kaskun O, et al
    ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma.
    Cancer Res. 2019 Jul 10. pii: 0008-5472.CAN-18-1357.
    PubMed         Abstract available


    J Invest Dermatol

  5. TAKABE P, Karna R, Rauhala L, Tammi M, et al
    Melanocyte hyaluronan coat fragmentation enhances the UVB-induced TLR-4 receptor signaling and expression of proinflammatory mediators IL-6, IL-8, CXCL-1 and CXCL-10 via NF-kappaB activation.
    J Invest Dermatol. 2019 Mar 29. pii: S0022-202X(19)31391.
    PubMed         Abstract available


    Lancet

  6. RIBAS A
    Triple therapy for BRAF(V600)-mutated melanoma.
    Lancet. 2020;395:1814-1815.
    PubMed        

  7. GUTZMER R, Stroyakovskiy D, Gogas H, Robert C, et al
    Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAF(V600) mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet. 2020;395:1835-1844.
    PubMed         Abstract available


    Lancet Oncol

  8. TAWBI H
    A promising start for checkpoint inhibitors in childhood malignancies.
    Lancet Oncol. 2020;21:13-14.
    PubMed        

  9. NORONHA C, Rocha L
    Meningeal melanocytosis: a challenging diagnosis.
    Lancet Oncol. 2019;20:e343.
    PubMed        


    Ophthalmology

  10. VAN IPENBURG JA, Gillis Ing AJM, Dorssers LCJ, van den Bosch QCC, et al
    MicroRNA Profiling in Benign and Malignant Conjunctival Melanocytic Lesions.
    Ophthalmology. 2019 Oct 12. pii: S0161-6420(19)32142.
    PubMed        


    PLoS One

  11. BUSS LA, Ang AD, Hock B, Robinson BA, et al
    Effect of post-implant exercise on tumour growth rate, perfusion and hypoxia in mice.
    PLoS One. 2020;15:e0229290.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: